| ||||
| HOME | ZACKS RESEARCH | FUNDS | PORTFOLIO | BROKER RESEARCH | MARKETS | SCREENING | VIDEO | EDUCATION | SERVICES |
|
|
|
|
Login | Free Membership |
|
 Sponsored Links  |
|
NASDAQ BIOTECHNOLOGY The NASDAQ Biotechnology Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals which also meet other eligibility criteria determined by the Funds Index Provider, NASDAQ OMX Group, Inc., including minimum market capitalization and liquidity requirements. ISHARES NASDAQ BIOTECHNOLOGY NYSE data is at least 20 minutes delayed.NASDAQ data is at least 15 minutes delayed.Zacks Commentary for IBBZacks Blog: Forget Big Pharma, It Is Time For A Biotech ETF Feb 09, 2012 Nov 22, 2011 Zacks Cook`s Kitchen: Biotech Investing Lessons: GILD Buys VRUS Dec 31, 1969 Jul 11, 2011 NewsPotential Nasdaq Biotechnology (IBB) Trade Has $119.36 Breakeven May 23, 2012 Potential Nasdaq Biotechnology (IBB) Trade Has $119.36 Breakeven - Story Title - Comtex May 23, 2012 Amicus Therapeutics Added to NASDAQ Biotechnology Index May 21, 2012 Pacira Pharmaceuticals, Inc. to Be Added to NASDAQ Biotechnology Index May 21, 2012 Amicus Therapeutics Added to NASDAQ Biotechnology Index - Story Title - Comtex May 21, 2012 |
| ||||||